New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.

AIM Evaluation and characterization of the vascularisation and perfusion of liver tumors by means of image fusion of dynamic contrast-enhanced ultrasound (CEUS), multidetector-CT (MD-CT) or magnetic resonance imaging (MRI) with the ultrasound navigation technique. MATERIAL For interventional planning a real-time image fusion involving CEUS (LOGIQ E9, GE) was performed in 20 patients (12 men, 8 women, age 43-69 years, median 54) with histologically confirmed malignant liver tumors (9 x hepatocellular carcinoma (HCC), 5 x metastases, 2 x hemangiomas, 1 x cholangiocellular carcinoma (CCC), 1 x lymphoma, 1 x neuroendocrine tumor, 1 x focal nodular hypoplasia (FNH)). In 17 patients the real-time CEUS was fused with contrast-enhanced MD-CT and in three patients with contrast-enhanced MRI (Gd-DTPA and liver-specific contrast medium Resovist. All of the ultrasound examinations were performed by an experienced examiner with a multi-frequency probe (2-5 MHz, LOGIQ E9, GE); dynamic image sequences up to 3 minutes in true agent detection mode of contrast harmonic imaging (CHI) were documented. An evaluation of the tumor was performed by the characterization of the dynamics of the contrast medium and microperfusion with CEUS, fused with MD-CT or MRI. RESULTS In 18/20 cases there was an accurate agreement with respect to the segmental localization of the tumor lesion. In 2/20 cases the localization was comparable with the image fusion of CEUS and reference imaging (a total of at least 65 lesions: 3 x 1 lesion, 5 x 2 lesions, 8 x 3 lesions, 2 x 5 lesions, 1 x 8 lesions, 1 x at least 10 lesions (multifocal)). With image fusion a certain characterization was attained in 17/20 cases. In 3/20 cases (lymphoma after liver transplantation, multifocal CCC, metastases of a neuroendocrine tumor) the diagnosis was at first doubtful and had to be confirmed histologically. In patients with HCC an evaluation of the tumor perfusion was feasible in all 9 cases (8/9 after local trans-arterial chemoembolization (TACE), 1/9 after radio frequency ablation (RFA)). A tendency toward the identification of more lesions with image fusion of CEUS and CT than with contrast-enhanced CT alone could be recognized (p=0.059). CONCLUSION Applying a new real-time fusion technique of MD-CT or MRI with CEUS new possibilities for the evaluation, intervention and monitoring of the therapy of liver lesions were made possible, since the method also comprised the dynamic microperfusion.

[1]  M. Miyazaki,et al.  Contrast‐enhanced three‐dimensional fusion sonography of small liver metastases with pathologic correlation , 2007, Journal of clinical ultrasound : JCU.

[2]  Nassir Navab,et al.  Real-Time Fusion of Ultrasound and Gamma Probe for Navigated Localization of Liver Metastases , 2007, MICCAI.

[3]  S. Lai,et al.  Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases. , 2009, Radiology.

[4]  E. Jung,et al.  Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison). , 2006, Clinical hemorheology and microcirculation.

[5]  M. Nielsen,et al.  Biopsy guided by real-time sonography fused with MRI: a phantom study. , 2008, AJR. American journal of roentgenology.

[6]  H. Weskott Emerging roles for contrast-enhanced ultrasound. , 2008, Clinical hemorheology and microcirculation.

[7]  M. Makuuchi,et al.  Early Hepatocellular Carcinoma: Pathology, Imaging, and Therapy , 2008, Annals of Surgical Oncology.

[8]  Wei Yang,et al.  Focal Liver Lesions: Can SonoVue-Enhanced Ultrasound Be Used to Differentiate Malignant From Benign Lesions? , 2007, Investigative radiology.

[9]  Carlo Bartolozzi,et al.  Targeting Liver Lesions for Radiofrequency Ablation: An Experimental Feasibility Study Using a CT–US Fusion Imaging System , 2008, Investigative radiology.

[10]  M. Oudkerk,et al.  Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. , 2006, World journal of gastroenterology.

[11]  Nassir Navab,et al.  Automatic CT-ultrasound registration for diagnostic imaging and image-guided intervention , 2008, Medical Image Anal..

[12]  M. Reiser,et al.  Contrast-enhanced ultrasound versus MS-CT in blunt abdominal trauma. , 2008, Clinical hemorheology and microcirculation.

[13]  K. Wolf,et al.  Liver metastases in cancer: detection with contrast-enhanced ultrasonography , 2004, Abdominal Imaging.

[14]  K J Wolf,et al.  Detection of Hepatic Metastases with low MI Real Time Contrast Enhanced Sonography and SonoVue® , 2005, Ultraschall in der Medizin.

[15]  G. Fattovich,et al.  Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and α-fetoprotein levels , 2008, La radiologia medica.

[16]  D A Clevert,et al.  Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study. , 2007, World journal of gastroenterology.

[17]  E. Jung,et al.  Vascularization and perfusion of hepatocellular carcinoma: assessment with contrast-enhanced ultrasound using perflutren protein-type A microspheres. , 2005, Clinical hemorheology and microcirculation.